×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Exploring Responder-Patient Clinical Study Design Approaches
Session Chair(s)
Joan Meyer
Covance, United States
Finding patients with a better chance of responding to a drug continues to evolve. This session will discuss how clinical trial design approaches can be employed, as well as how stakeholders can collaborate to accelerate advancements.
Learning Objective : Discuss the concept of a responder in a clinical trial; Describe ways to use data to increase the recruitment of responders into clinical studies.
Speaker(s)
Industry Perspective
Joan Meyer
Covance, United States
FDA Perspective on Use of Biomarkers to Identify Treatment Responders
Christopher Leptak, MD, PhD
Greenleaf Health, Inc., United States
Executive Vice President, Drug and Biological Products
Pharmaceutical Perspective
Cecile Holweg
Genentech, A Member of the Roche Group, United States
Have an account?